TOP STORIESeNEWSLETTER
  • Preliminary Research Suggests Unintended Benefit From Medical Cannabis
    Results of a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health and the Philadelphia Veterans Affairs Medical Center indicate that states that have legalized medical marijuana to manage chronic pain and other conditions are experiencing a 25% lower death rate from prescription drug overdose than in states where medical marijuana remains illegal. California, Oregon, and Washington legalized medical marijuana prior to 1999, with 10 more states following between then and 2010, the time period of the study. As of June 2014, another 10 states and Washington, D.C. have adopted similar laws. The authors write that, while more research is needed, their findings suggest that wider availability of medical marijuana for people in pain might help to reduce the growing number of overdose deaths attributed to prescription pain medications. A report on the research appears in the August 25 issue of JAMA Internal Medicine. Read a news story about the findings here.
    MORE
  • To address symptoms following breast cancer surgery, patients need to be treated on an individual basis
    For those affected, breast cancer is a dramatic diagnosis. Patients often have to endure chemotherapy and surgery, which, depending on the individual scenario, may mean breast conserving surgery or... Pain / Anesthetics News From Medical News Today
    MORE
  • Iroko Pharmaceuticals gains FDA approval of ZORVOLEX® for management of osteoarthritis pain
    Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, has announced the United States Food and Drug Administration (FDA) has... Pain / Anesthetics News From Medical News Today
    MORE
  • Research Suggests Modifications to Therapy may be Indicated
    New research published this week in the journal Scientific Reports suggests that methadone treatment may need to change to address a side-effect: alteration in testosterone levels among male patients receiving the therapy. Low testosterone in men has been associated with poor quality of life as well as erectile dysfunction, fatigue, and mood disturbances. Methadone, which is used for opioid addiction treatment, was found to significantly suppress testosterone levels in men who were opioid users, compared to men not using opioids. In women using methadone for addiction treatment, testosterone levels were not significantly impacted, even considering the menstrual cycle. Study recommendations include providing treatment for testosterone deficiency, as well as engaging the lowest possible doses of opioids including methadone to minimize suppression. Read a news story about the research findings here.
    MORE
 
Daniel Carr, MD, FABPM
Director
Pain Research, Education, and Policy Program
Department of Public Health and Community Medicine
Tufts Medical Center
Boston, MA

SIGN UP

…for the latest information from PAINWeek, the Pain Education Resource for Frontline Practitioners!